Our Road to GMP continues with an important step in the authorisation process with AIFA to operate in accordance with GMP standards as an analytical laboratory for the quality control of biological drugs.
A significant step in a path that has led us to invest in specialised expertise, infrastructure and quality management systems, with the goal of expanding the services we offer to the pharmaceutical sector.
The authorisation request covers three areas of activity:
- Quality control of authorised medicinal products
- Quality control of investigational medicinal products
- Quality control in the context of importation from non-EU countries of both authorised and investigational medicinal products.
Our aim is to support pharmaceutical companies by performing the analyses required to verify product compliance, providing analytical data to support subsequent batch certification and release activities.
A new phase now begins: the evaluation by AIFA.
The authorisation process also includes an inspection to verify compliance with GMP requirements, through the assessment of infrastructure, laboratories, warehouses and archives, as well as documentation and the quality management system.
The journey continues — but today we can pause for a moment to mark an important milestone on the map: the application has officially been submitted.